Catalyst Wire Dossier Catalyst Wire Dossier

Radium-223 dichloride

radium-223 dichloride · Bayer
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for Radium-223 dichloride, covering 2017-07-02 to 2026-02-19. Get the full timeline:

Most recent: Clinical Trial Update: Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis [Phase 1, Phase 2]

See pricing